Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | A plain language summary of the results from the group of patients in the CHRYSALIS study with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab | FUTURE ONCOLOGY |